Stefano Lise

Stefano Lise

University College London

H-index: 36

Europe-United Kingdom

About Stefano Lise

Stefano Lise, With an exceptional h-index of 36 and a recent h-index of 25 (since 2020), a distinguished researcher at University College London, specializes in the field of Bioinformatics, Computational Biology, Cancer Genomics, Translational Research.

His recent articles reflect a diverse array of research interests and contributions to the field:

Driver mutations in GNAQ and GNA11 genes as potential targets for precision immunotherapy in uveal melanoma patients

Copy number architectures define treatment-mediated selection of lethal prostate cancer clones

Accumulation of copy number alterations and clinical progression across advanced prostate cancer

Treatment-mediated selection of lethal prostate cancer clones defined by copy number architectures

Abstract P080: Analysis of clinical BRCA1/2 reversions identifies hotspot mutations and predicted neoantigens associated with therapy resistance

The immunogenic potential of recurrent cancer drug resistance mutations: an in silico study

Clinical BRCA1/2 Reversion Analysis Identifies Hotspot Mutations and Predicted Neoantigens Associated with Therapy Resistance

Genome-wide plasma DNA methylation features of metastatic prostate cancer

Stefano Lise Information

University

Position

UCL Cancer Institute

Citations(all)

4185

Citations(since 2020)

1907

Cited By

3064

hIndex(all)

36

hIndex(since 2020)

25

i10Index(all)

46

i10Index(since 2020)

34

Email

University Profile Page

Google Scholar

Stefano Lise Skills & Research Interests

Bioinformatics

Computational Biology

Cancer Genomics

Translational Research

Top articles of Stefano Lise

Driver mutations in GNAQ and GNA11 genes as potential targets for precision immunotherapy in uveal melanoma patients

Oncoimmunology

2023/12/31

Copy number architectures define treatment-mediated selection of lethal prostate cancer clones

Nature communications

2023/8/10

Accumulation of copy number alterations and clinical progression across advanced prostate cancer

Genome Medicine

2022/9/5

Treatment-mediated selection of lethal prostate cancer clones defined by copy number architectures

bioRxiv

2022/9/3

Abstract P080: Analysis of clinical BRCA1/2 reversions identifies hotspot mutations and predicted neoantigens associated with therapy resistance

Molecular Cancer Therapeutics

2021/12/1

The immunogenic potential of recurrent cancer drug resistance mutations: an in silico study

Frontiers in Immunology

2020/10/8

Marco Punta
Marco Punta

H-Index: 22

Stefano Lise
Stefano Lise

H-Index: 22

Clinical BRCA1/2 Reversion Analysis Identifies Hotspot Mutations and Predicted Neoantigens Associated with Therapy Resistance

Cancer discovery

2020/10/1

Genome-wide plasma DNA methylation features of metastatic prostate cancer

The Journal of clinical investigation

2020/6/15

Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer

Nature communications

2020/1/16

Marco Punta
Marco Punta

H-Index: 22

Stefano Lise
Stefano Lise

H-Index: 22

See List of Professors in Stefano Lise University(University College London)

Co-Authors

academic-engine